Record Details

Management of cryptococcal meningitis in adults at Mthatha Hospital Complex, Eastern Cape, South Africa

Southern African Journal of HIV Medicine


 
 
Field Value
 
Title Management of cryptococcal meningitis in adults at Mthatha Hospital Complex, Eastern Cape, South Africa
 
Creator Sogbanmu, Olufunso Oladipupo; Cecilia Makiwane Hospital, Eastern Cape Department of Health, East London, South Africa John, Melanie-Anne Amanda; Enhancing Care Initiative, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban; and Infectious Diseases Department, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa Lalloo, Umesh; Enhancing Care Initiative, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
 
Subject HIV Medicine; Infectious Diseases Cryptococcal meningitis; Amphotericin B; South African HIV Clinicians Society guideline; HIV/AIDS HIV-associated opportunistic infections
Description Background. Cryptoccocal meningitis (CM) remains prevalent in HIV-infected individuals across South Africa (SA). Early diagnosis and management, aided by the existing Southern African HIV Clinicians Society (SAHIVSoc) 2007 guidelines on management of CM, could reduce the mortality associated with this condition. Objective. To review the management of adult patients with CM and adherence to the SAHIVSoc 2007 guidelines in a district hospital.Methods. A retrospective chart review of patients admitted with CM from December 2011 to May 2012 was performed. The following key recommendations of the guidelines were evaluated: measurement of cerebrospinal fluid (CSF) opening pressure at the first lumbar puncture (LP), prescription of amphotericin B (AMB)/fluconazole therapy, intravenous prehydration preceding administration of AMB, monitoring of renal function and performance of serial LPs to manage raised intracranial pressure (ICP).Results. A total of 57 patient charts were reviewed, of which 40 (70%) were of females. The mean age (range) of the cohort was 36 (21 - 60) years. Fifty-two (91%) patients presented with headache. Confusion was recorded in 30 (53%) and vomiting in 26 (46%). The major signs observed were fever (n=29 (51%)) and neck stiffness (n=34 (60%)). Fifty-five (96%) patients were HIV-infected at presentation, with a median (range) CD4+ count of 77 (13 - 90) cells/µl. None of the patients had a CSF opening pressure measured at first LP. AMB was used as an induction agent in 51 (89%) patients, of whom 47 (92%) completed 2 weeks of AMB. Of these 51, only 20 (40%) were prehydrated and 10 (18%) had two repeat LPs performed 1 week apart. Renal function was monitored in only 27 (53%) of the patients receiving AMB. This was done at baseline and twice weekly, and was consistent with the guidelines. No abnormality in renal function was recorded in these cases during the study. The mortality rate was 30% in the first 10 days of admission.Conclusion. This chart review showed inadequate adherence to the recommendations of the 2007 SAHIVSoc guidelines in the majority of cases except for the use of AMB as a first-line antifungal agent. Control of ICP and monitoring for drug toxicity were not done as per guidelines and may impact on clinical care and outcome. Despite this, the early 30% mortality is comparable with published reports from other regions in SA, but is higher than in developed health systems.
 
Publisher AOSIS Publishing
 
Date 2014-09-08
 
Type — Retrospective chart review
Format application/pdf
Identifier 10.4102/hivmed.v15i3.10
 
Source Southern African Journal of HIV Medicine; Vol 15, No 3 (2014); 104-107
 
Language en
 
Coverage South Africa; Eastern Cape; Mthatha December 2011 and May 2012 Adults, male and female
Rights Copyright information Ownership of copyright in terms of the Work remains with the authors.The authors retain the non-exclusive right to do anything they wish with the Work, provided attribution is given to the place and detail of original publication, as set out in the official citation of the Work published in the journal. The retained right specifically includes the right to post the Work on the authors’ or their institutions’ websites or institutional repository.Publication and user license The authors grant the title owner and the publisher an irrevocable license and first right and perpetual subsequent right to (a) publish, reproduce, distribute, display and store the Work in  any form/medium, (b) to translate the Work into other languages, create adaptations, summaries or extracts of the Work or other derivative works based on the Work and exercise all of the rights set forth in (a) above in such translations, adaptations, summaries, extracts and derivative works, (c) to license others to do any or all of the above, and (d) to register the Digital Object Identifier (DOI) for the Definitive Work.The authors acknowledge and accept the user licence under which the Work will  be published as set out in http://creativecommons.org/licenses/by/2.5/za/legalcode (Creative Commons Attribution License South Africa)The undersigned warrant that they have the authority to license these publication rights and that no portion of the copyright to the Work has been assigned or licensed previously to any other party.Disclaimer: The publisher, editors and title owner accept no responsibility for any statement made or opinion expressed by any other person in this Work. Consequently, they will not be liable for any loss or damage sustained by any reader as a result of his or her action upon any statement or opinion in this Work. In cases where a manuscript is NOT accepted for publication by the editorial board, the portions of this agreement regarding the publishing licensing shall be null and void and the authors will be free to submit this manuscript to any other publication for first publication.Our copyright policies are author-friendly and protect the rights of our authors and publishing partners.